Making Money With Your Business, Profit and Cash Flow, Five Sustainable Companies That Make a Lot of MoneyFind Angel Funding & Venture Capital for Business Startups, Entrepreneurs, & First Time Founders – Episode 10

Making Money With Your Business, Profit and Cash Flow, Five Sustainable Companies That Make a Lot of Money

Find Angel Funding & Venture Capital for Business Startups, Entrepreneurs, & First Time Founders – Episode 10

It is time to make money! You have been through a couple of rounds of market testing now you feel like you are on to something. The next step is to run the numbers to make sure that the business is sustainable. There are two sides to making money, profitability and cash flow.

Profitability is the difference between the expenditures of a business and its revenues. Typically, businesses sell their products or serviced for more than their purchase price or costs. The difference between revenue and expenses is profit. For example, if you buy a car for $5,000 and sell it for $7,000, you make a $2,000 profit.

Positive cash flow is different. It means more money is coming in than going out, and you have enough cash in your business bank account to pay your bills. There is a significant difference.

In the previous example, you bought a car for $5,000 and sold for $7,000. If you purchased the car using a credit card and sold the car immediately, your current cash flow would be $7,000. You sold the car before you paid for it. When you pay off the car, your cash flow will match your profit of $2,000. This is assuming no interest expense. 

If you did keep a balance on your credit card or did not pay off the car immediately, your interest expense will reduce your profitability and cash flow, If you never pay your credit card, your cash flow from the transaction will remain $7,000. 

Cash flow can be used to repay creditors, pay dividends and interest to investors, engage in buybacks, investments in acquisitions for inorganic growth, investments in innovation for organic growth, or debt reduction.

More cash allows for more maneuverability for a company. This can allow for positive growth during economic booms and flexibility during an economic downturn, regardless of the cause of those bad times, e.g. the broader market, the industry, or the company itself.

Here are five examples of companies that have consistently make a lot of money.

Company Name
Free Cash Flow (FCF)
Debt to Equity Ratio (D/E) 
1-Year Stock Performance
Dividend Yields

Apple (APPL)
 $7.17 billion (TTM ended in 06/20) 
0.61 (for the three months ending 06/30/20)
55.38% (since 12/31/19)
0.71% (as of 8/13/20)

Verizon (VZ)
$2.11 billion (TTM ended in 06/20)
1.94 (for the three months ending 06/30/20)
-4.39% (since 12/31/19)
4.20% (as of 8/13/20)
 
Microsoft (MSFT)
$4.52 billion (TTM ended in 06/20)
0.57 (for the three months ending 06/30/30)
32.47% (since 12/31/19)
0.98% (as of 8/13/20)
 
Walmart (WMT)
 $1.84 billion (TTM ended in 04/20)
0.85 (for the three months ending 04/30/20)
11.58% (since 12/31/19)
2.85% (as of 8/13/20)
 
Pfizer (PFE)
$1.26 billion (TTM ended in 06/20)
0.78 (for the three months ended in 06/30/20)
 -2.86% (since 12/31/19)
3.99% (as of 8/13/20)


Do you want more? 
https://rencarlton.blogspot.com/2021/07/making-money-with-your-business-profit.html 
https://youtu.be/rNiu6b8ICUg
https://www.linkedin.com/pulse/making-money-your-business-profit-cash-flow-five-make-ren-carlton

Previous Post - Starting to Grow, How Rushing to Market Turned Crystal Pepsi Into One of the Worst Product Fails of All Time, Even After Half a Billion of Sales in Its First Year - Find Angel Funding & Venture Capital for Business Startups, Entrepreneurs, & First Time Founders – Episode 9
https://rencarlton.blogspot.com/2021/06/starting-to-grow-how-rushing-to-market.html
https://youtu.be/drfO0TxRpWE
https://www.linkedin.com/pulse/starting-grow-how-rushing-market-turned-crystal-pepsi-ren-carlton

Are you looking for investors? Send us your information, Funding@OmegaAccelerator.com

Would you like to invest in early-stage businesses? Contact us, info@omegaaccelerator.com


Sources
https://www.investopedia.com/terms/c/cashflow.asp
https://www.investopedia.com/terms/p/profit.asp
https://www.investopedia.com/articles/investing/060116/5-companies-huge-cash-flow-aaplvzmsftwmt.asp
https://www.nasdaq.com/articles/microsoft-is-worth-more-based-on-its-powerful-free-cash-flow-2021-01-13


Disclaimer: This does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service. We are not offering legal, investment, tax, or medical advice

The Alienation Of America’s Best Doctors

The best and the brightest simply don’t want to become doctors anymore. Physicians are burning out. They are leaving the profession. They are going bankrupt. They are selling their private practices to big hospitals. They are retiring early. We are facing a growing doctor shortage.

Better to Live and Die in the U.S.A.

The United States healthcare system is often berated for how it treats patients near the end of life. They are purportedly attached to tubes and machines and subjected to unnecessary invasive procedures that cause inordinate pain with no potential benefit, there is underutilization of more compassionate hospice services. This “travesty” is expensive, as the care of dying seniors consumes over 25% of Medicare expenditures. We hear this story so often; it is almost taken as gospel-- but is it actually true? Is it more expensive and invasive to die in America than in other developed countries?

Gun Ownership and Doctors?

According to the Pew Research Center, there are approximately 32,000 gun-related deaths annually in the United States; 19,000 are suicide, 11,000 are homicide, and the rest are accidents, police shootings or of unknown causation. Moreover, there are more than 78,000 nonfatal gun wounds each year. Given the disproportionate number of victims that are less than 40 years of age, the morbidity and mortality of gun violence is significant. Physicians are involved with many types of public health issues, but few are as controversial or divisive as gun safety. Is it really an issue that falls within the medical domain?

O Tempora, O Mores: Affordable Care Act - Big Dream or Big Let Down?

I confess I was a strong proponent of the Affordable Care Act. My reasoning was subtler than the hallowed pantheons of its staunch supporters and the apocalyptic predictions of its detractors. Forty years after graduating medical school I concluded, after many stutter steps, the American healthcare delivery system was economically unsustainable and the citizenry was neither living longer, nor better, despite medical expenditures that dwarf any other developed nation. My career also allowed me to personally interact with cardiac surgeons from all continents and see that their clinical results and research efforts were laudatory by any standards.

High Depression Rates in Resident Physicians — Fact or Fiction?

The December 8, 2015 issue of JAMA had a startling key clinical point; the prevalence of depression or depressive symptoms among resident physicians in training was 28.8%. The data was generated by meta-analysis of 31 cross-sectional and 23 longitudinal studies published in peer-reviewed journals involving 17,560 trainees. Two-thirds of the trainees were in North America, but the others were from Asia, Europe, South America, and one from Africa. Sensitivity-analysis confirmed that no individual study affected overall prevalence by more than 1% and that the incidence of depression was not influenced by study design, continent of origin, surgical vs nonsurgical program nor level of residency year.

Can a Robot Outperform Your Surgeon?

In the current competitive environment, healthcare providers often attempt to separate themselves from their competition by marketing themselves as using the newest technologies for their procedures. This is an age defined by finding the next best thing and the American public responds to this strategy. My personal experience has been in cardiac surgery, but the principles are equally applicable to other specialties, particularly tertiary referral practices.

Hospital Administration Attempts to Cut Costs and Increase Quality at Expense of Physicians

A nonprofit hospital care system in Oregon with 450 beds has been in an acrimonious negotiation with its staff hospitalists for the past 2 years. The mounting economic pressures on this small, community oriented institution have had the expected consequences of hiring new administrators to implement the latest trends to rein in the budget and effect efficiencies of healthcare delivery-- as if that has been so successful in the rest of the country. The battle has really centered over the physicians losing control of their work time allocation, individual decision-making for diagnostic and treatment plans, as well as bristling at bonuses based on the administration’s definition of quality.

Michigan Physicians Society Supports Inner-City Education

Yesterday afternoon I had the privilege of helping to honor the graduating class of 2016 at Experiencia Preparatory Academy. They have 3 graduates this year that have overcome a special set of challenges, including moving from Mexico to the United States and having English as a second language.

Affordable Care Act: Affordable for whom?

Entering its third annual open enrollment period, Obamacare is the subject of cacophonous political acrimony, again, championed by its supporters and vilified by its opponents. Each side presents its own “metrics” of success or failure

Big Pharma Using Mail-Order Pharmacies to Maintain High Prices

The United States has the dubious honor of paying the highest prescription drug costs in the world. Many healthcare economists attribute this to relatively lax cost regulation compared to other wealthy countries; however, a decade of insurers paying only for generic drugs when available and limiting drug choice in specific formularies has had little modulating effect.

Mental Health Spending: A Story of Failed Supply and Demand

Several weeks ago I was in Palo Alto, California walking along Camino Real abutting the Stanford University campus. I noticed a newly-constructed high-link fence isolating the commuter train tracks from the pedestrian walkways. Another “shovel-ready” infrastructure project to nurture the economy?

Photos - MPS Auto Show Event - Lingenfelter Collection!

Our auto show event at the Lingenfelter Collection was a huge success! Approximately 100 attendees enjoyed an evening of learning, networking, and fun at the Lingenfelter Collection, one of the most notable car collections in the world! A special thanks to M1 Concourse and the Lingenfelter Collection for sponsoring this event.

Michigan Physicians Society Auto Show Event - Lingenfelter Collection!

We are excited to announce our next MPS event! MPS members will enjoy an exciting evening of learning, networking, and fun at the Lingenfelter Collection, one of the most notable car collections in the world! Learn about car collecting as an alternative investment strategy while enjoying a private tour of the Lingenfelter Collection.

Physicians Role in Drug Pricing

Two new drugs, Repatha and Praluent, were approved by the Food and Drug Administration several months ago amid much ballyhoo. Both are antibodies that specifically target PCSK9, a protein which reduces the number of receptors on the liver that remove LDL cholesterol from the blood. By blocking PCSK9’s ability to work, more receptors are available to clear LDL. This novel mechanism was proven safe and effective in clinical trials, lowering LDL cholesterol levels by 40% or more in patients already taking statin drugs. However, powerful treatment comes with a powerful cost-- over $14,000 per year for each patient.

Physician or Salesperson? - The Ethics Behind Patient Donors

Maybe it’s because we have entered the silly season with a full cast of presidential aspirants, but I have recently mulling over the perception of behavioral impropriety. To translate from spin doctor to medical doctor, I mean professional behavior that may not be overtly unethical, but exudes self-interest over patient well-being. In the academic world, full disclosure includes financial interest with potential conflict, disclaimer of previous publications, responsibility for informed consent and approval by the appropriate research committee. In our practices, particularly in the clinic or hospital setting, much focus is on constructing a firewall between the pharmaceutical and the medical-device sales force and medical providers.
Page: 1234 - All